EDGAR Filing Documents for 0001209191-17-027835

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0001209191-17-027835

Filing Date

2017-04-21

Accepted

2017-04-21 16:32:09

Documents

Period of Report

2017-04-19

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 3 SUBMISSION	doc3.html	3
1	FORM 3 SUBMISSION	doc3.xml	3	1583
2	POA DOCUMENT	poa.txt	EX-24.3_719159	4500
	Complete submission text file	0001209191-17-027835.txt		7584

Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025

Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269

Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INOTEK PHARMACEUTICALS CORPORATION 131 HARTWELL AVENUE, SUITE 105 LEXINGTON MA 02421

Business Address

Type: 3 | Act: 34 | File No.: 001-36579 | Film No.: 17776277